{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:54:54Z","timestamp":1781643294576,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Papillary thyroid carcinoma (PTC) represents the most prevalent subtype of thyroid cancer. Accumulating evidence indicates that specific microRNAs are consistently dysregulated in PTC and may hold value as biomarker candidates. Accordingly, this study aims to prioritize consistently upregulated microRNAs associated with PTC using an integrative in silico analysis of publicly available datasets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study conducted a comprehensive analysis of miRNA expression patterns using datasets available through A Database of Differentially Expressed miRNAs in Human Cancers (dbDEMC). The dataset was then processed through a data mining approach with a cutoff of P-value\u2009&lt;\u20090.05 and log\n                      <jats:sub>2<\/jats:sub>\n                      FC\u2009&gt;\u20091.5 to identify miRNAs that were significantly and consistently upregulated in the datasets. The target genes are predicted through miRDIP, miRTarBase, miRPathDB, and GEPIA2. Gene ontology and pathway enrichment analysis were performed in ShinyGO and EnrichR. To assess the diagnostic ability of the three miRNAs, CancerMIRNome is used to identify the ROC curve analysis results of each miRNA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This exploratory in silico analysis identified 85 differentially expressed miRNAs in PTC, with hsa-miR-221-3p, hsa-miR-222-3p, and hsa-miR-146b-5p consistently upregulated across datasets. Functional enrichment and TCGA-based ROC analyses suggest that these miRNAs may have biological and discriminatory relevance in PTC. However, these findings are hypothesis-generating and require further experimental and clinical validation before any diagnostic application can be considered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In summary, our study identified the potential of hsa-miR-221-3p, hsa-miR-222-3p, and hsa-miR-146b-5p as potential diagnostic biomarkers of PTC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43046-026-00350-1","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T23:03:11Z","timestamp":1776034991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An insilico analysis: three upregulated microRNAs as potential diagnostic biomarkers of Papillary Thyroid Carcinoma (PTC)"],"prefix":"10.1186","volume":"38","author":[{"given":"Maharani Putri","family":"Hermawan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari Eka","family":"Pratiwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridha","family":"Ulfah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eko Rustianto","family":"Suhardiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahyarudin","family":"Mahyarudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"350_CR1","volume-title":"Kanker Tiroid: Penjelasan Komprehensif Tentang Kanker Tiroid","author":"KB Siregar","year":"2023","unstructured":"Siregar KB. Kanker Tiroid: Penjelasan Komprehensif Tentang Kanker Tiroid. Medan: USU Press; 2023."},{"issue":"6","key":"350_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"350_CR3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"350_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3238\/arztebl.2016.0353","volume":"113","author":"J Feldkamp","year":"2016","unstructured":"Feldkamp J, F\u00fchrer D, Luster M, et al. Fine needle aspiration in the investigation of thyroid nodules. Dtsch Arztebl Int. 2016;113(20):353\u20139. https:\/\/doi.org\/10.3238\/arztebl.2016.0353.","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"350_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020.","journal-title":"Thyroid"},{"issue":"2","key":"350_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/jso.23967","volume":"112","author":"F-H Liu","year":"2015","unstructured":"Liu F-H, Kuo S-F, Hsueh C, et al. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis. J Surg Oncol. 2015;112(2):149\u201354. https:\/\/doi.org\/10.1002\/jso.23967.","journal-title":"J Surg Oncol"},{"key":"350_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137167","author":"PTB Ho","year":"2022","unstructured":"Ho PTB, Clark IM, Le LTT. Microrna-based diagnosis and therapy. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23137167.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"350_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ncrna.2020.06.001","volume":"5","author":"S Ghafouri-Fard","year":"2020","unstructured":"Ghafouri-Fard S, Shirvani-Farsani Z, Taheri M. The role of microRNAs in the pathogenesis of thyroid cancer. Noncoding RNA Res. 2020;5(3):88\u201398. https:\/\/doi.org\/10.1016\/j.ncrna.2020.06.001.","journal-title":"Noncoding RNA Res"},{"key":"350_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.755097","author":"M Papaioannou","year":"2022","unstructured":"Papaioannou M, Chorti AG, Chatzikyriakidou A, et al. Micrornas in papillary thyroid cancer: what is new in diagnosis and treatment. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2021.755097.","journal-title":"Front Oncol"},{"issue":"1","key":"350_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4302-0","volume":"18","author":"C Jean-Quartier","year":"2018","unstructured":"Jean-Quartier C, Jeanquartier F, Jurisica I, et al. In silico cancer research towards 3R. BMC Cancer. 2018;18(1):408. https:\/\/doi.org\/10.1186\/s12885-018-4302-0.","journal-title":"BMC Cancer"},{"issue":"3","key":"350_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.gpb.2022.04.006","volume":"20","author":"F Xu","year":"2022","unstructured":"Xu F, Wang Y, Ling Y, et al. dbDEMC 3.0: functional exploration of differentially expressed miRNAs in cancers of human and model organisms. Genomics Proteomics Bioinformatics. 2022;20(3):446\u201354. https:\/\/doi.org\/10.1016\/j.gpb.2022.04.006.","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"1","key":"350_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/NAR\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207\u201310. https:\/\/doi.org\/10.1093\/NAR\/30.1.207.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"350_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-76603-3","volume":"10","author":"J Goedhart","year":"2020","unstructured":"Goedhart J, Luijsterburg MS. VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots. Sci Rep. 2020;10(1):1\u20135. doi: 10.1038\/S41598-020-76603-3;SUBJMETA=114,1647,2399,631,794,80;KWRD=CELL+BIOLOGY,COMMUNICATION+AND+REPLICATION,COMPUTATIONAL+BIOLOGY+AND+BIOINFORMATICS,SOFTWARE.","journal-title":"Sci Rep"},{"key":"350_CR14","unstructured":"Demsar J, Curk T, Erjavec A et al. Orange: Data Mining Toolbox in Phyton. J Mach Learn Res. 2013;2349\u2013535."},{"issue":"D1","key":"350_CR15","doi-asserted-by":"publisher","first-page":"D217","DOI":"10.1093\/nar\/gkac1070","volume":"51","author":"A-C Hauschild","year":"2023","unstructured":"Hauschild A-C, Pastrello C, Ekaputeri GKA, et al. MirDIP 5.2: tissue context annotation and novel microRNA curation. Nucleic Acids Res. 2023;51(D1):D217\u201325. https:\/\/doi.org\/10.1093\/nar\/gkac1070.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"350_CR16","doi-asserted-by":"publisher","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","volume":"50","author":"H-Y Huang","year":"2022","unstructured":"Huang H-Y, Lin Y-C-D, Cui S, et al. miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 2022;50(D1):D222\u201330. https:\/\/doi.org\/10.1093\/nar\/gkab1079.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"350_CR17","doi-asserted-by":"publisher","first-page":"D142","DOI":"10.1093\/nar\/gkz1022","volume":"48","author":"T Kehl","year":"2020","unstructured":"Kehl T, Kern F, Backes C, et al. miRPathDB 2.0: a novel release of the miRNA pathway dictionary database. Nucleic Acids Res. 2020;48(D1):D142\u20137. https:\/\/doi.org\/10.1093\/nar\/gkz1022.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"350_CR18","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u201360. https:\/\/doi.org\/10.1093\/nar\/gkz430.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"350_CR19","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90-7. https:\/\/doi.org\/10.1093\/nar\/gkw377.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"350_CR20","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020;36(8):2628\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btz931.","journal-title":"Bioinformatics"},{"issue":"1","key":"350_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.21873\/invivo.12262","volume":"35","author":"P CELAKOVSKY","year":"2021","unstructured":"CELAKOVSKY P, KOVARIKOVA H. MicroRNA deregulation in papillary thyroid cancer and its relationship with BRAF V600E mutation. Vivo (Brooklyn). 2021;35(1):319\u201323. https:\/\/doi.org\/10.21873\/invivo.12262.","journal-title":"Vivo (Brooklyn)"},{"issue":"6","key":"350_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180660","volume":"12","author":"B Liang","year":"2017","unstructured":"Liang B, Zhao J, Wang X. A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: an In Silico analysis. PLoS One. 2017;12(6):e0180660. https:\/\/doi.org\/10.1371\/journal.pone.0180660.","journal-title":"PLoS One"},{"issue":"4","key":"350_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/tjem.tjem_182_23","volume":"23","author":"\u015e Corbacioglu","year":"2023","unstructured":"Corbacioglu \u015e, Aksel G. Receiver operating characteristic curve analysis in diagnostic accuracy studies: a guide to interpreting the area under the curve value. Turk J Emerg Med. 2023;23(4):195. https:\/\/doi.org\/10.4103\/tjem.tjem_182_23.","journal-title":"Turk J Emerg Med"},{"issue":"3","key":"350_CR24","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1097\/MJT.0000000000000420","volume":"24","author":"Y Diao","year":"2017","unstructured":"Diao Y, Fu H, Wang Q. MiR-221 exacerbate cell proliferation and invasion by targeting TIMP3 in papillary thyroid carcinoma. Am J Ther. 2017;24(3):e317-28. https:\/\/doi.org\/10.1097\/MJT.0000000000000420.","journal-title":"Am J Ther"},{"issue":"3","key":"350_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1089\/thy.2017.0127","volume":"28","author":"I Jahanbani","year":"2018","unstructured":"Jahanbani I, Al-Abdallah A, Ali RH, et al. Discriminatory miRNAs for the management of papillary thyroid carcinoma and noninvasive follicular thyroid neoplasms with papillary-like nuclear features. Thyroid. 2018;28(3):319\u201327. https:\/\/doi.org\/10.1089\/thy.2017.0127.","journal-title":"Thyroid"},{"key":"350_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.canlet.2018.11.026","volume":"443","author":"M Jia","year":"2019","unstructured":"Jia M, Shi Y, Li Z, et al. MicroRNA-146b-5p as an oncomiR promotes papillary thyroid carcinoma development by targeting CCDC6. Cancer Lett. 2019;443:145\u201356. https:\/\/doi.org\/10.1016\/j.canlet.2018.11.026.","journal-title":"Cancer Lett"},{"key":"350_CR27","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2019-0027","author":"M-R Mahmoudian-Sani","year":"2020","unstructured":"Mahmoudian-Sani M-R, Amrollahi-Sharifabadi M, Taheri A, et al. Diagnostic value of the candidate micrornas in thyroid fine-needle aspiration biopsy (FNAB) samples. Horm Mol Biol Clin Invest. 2020. https:\/\/doi.org\/10.1515\/hmbci-2019-0027.","journal-title":"Horm Mol Biol Clin Invest"},{"issue":"6","key":"350_CR28","doi-asserted-by":"publisher","first-page":"862","DOI":"10.17305\/bjbms.2022.7343","volume":"22","author":"Y Chen","year":"2022","unstructured":"Chen Y, Dong B, Huang L, et al. Serum microRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma: a meta-analysis. Bosn J Basic Med Sci. 2022;22(6):862\u201371. https:\/\/doi.org\/10.17305\/bjbms.2022.7343.","journal-title":"Bosn J Basic Med Sci"},{"key":"350_CR29","doi-asserted-by":"publisher","unstructured":"Dean B, Geropoulos G, Richardson-Jones T et al. Diagnostic accuracy of circulating miR-146, miR-221 and miR-222 in papillary thyroid cancer: a systematic review and meta-analysis. http:\/\/www.wjgnet.com\/. 2025;13(27).\u00a0https:\/\/doi.org\/10.12998\/WJCC.V13.I27.104916.","DOI":"10.12998\/WJCC.V13.I27.104916"},{"issue":"3","key":"350_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/genes15030389","volume":"15","author":"M Matos","year":"2024","unstructured":"Matos M, Pinto M, Alves M, et al. Cyto-histological profile of microRNAs as diagnostic biomarkers in differentiated thyroid carcinomas. Genes. 2024;15(3):389. https:\/\/doi.org\/10.3390\/genes15030389.","journal-title":"Genes"},{"key":"350_CR31","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.omtn.2022.02.005","volume":"27","author":"MT Di Martino","year":"2022","unstructured":"Di Martino MT, Arbitrio M, Caracciolo D, et al. MiR-221\/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: a systematic review. Mol Ther Nucleic Acids. 2022;27:1191\u2013224. https:\/\/doi.org\/10.1016\/j.omtn.2022.02.005.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"350_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/GM272","volume":"3","author":"MY Shah","year":"2011","unstructured":"Shah MY, Calin GA. MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med. 2011;3(8):56. https:\/\/doi.org\/10.1186\/GM272.","journal-title":"Genome Med"},{"issue":"1","key":"350_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7252013","volume":"2019","author":"Q Song","year":"2019","unstructured":"Song Q, An Q, Niu B, et al. Role of miR-221\/222 in tumor development and the underlying mechanism. J Oncol. 2019;2019(1):7252013. https:\/\/doi.org\/10.1155\/2019\/7252013.","journal-title":"J Oncol"},{"key":"350_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092608","author":"CA Silaghi","year":"2020","unstructured":"Silaghi CA, Lozovanu V, Silaghi H, et al. The prognostic value of micrornas in thyroid cancers\u2014a systematic review and meta-analysis. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12092608.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"350_CR35","doi-asserted-by":"publisher","first-page":"683","DOI":"10.17305\/bjbms.2021.7399","volume":"22","author":"E Sheikh","year":"2022","unstructured":"Sheikh E, Tran T, Vranic S, et al. Role and significance of c-KIT receptor tyrosine kinase in cancer: a review. Bosn J Basic Med Sci. 2022;22(5):683\u201398. https:\/\/doi.org\/10.17305\/bjbms.2021.7399.","journal-title":"Bosn J Basic Med Sci"},{"issue":"3","key":"350_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173913","volume":"12","author":"S Franceschi","year":"2017","unstructured":"Franceschi S, Lessi F, Panebianco F, et al. Loss of c-KIT expression in thyroid cancer cells. PLoS One. 2017;12(3):e0173913. https:\/\/doi.org\/10.1371\/journal.pone.0173913.","journal-title":"PLoS One"},{"key":"350_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.851","author":"Z Luo","year":"2023","unstructured":"Luo Z, Xu J, Xu D, et al. Mechanism of immune escape mediated by receptor tyrosine kinase KIT in thyroid cancer. Immunity Inflamm Dis. 2023. https:\/\/doi.org\/10.1002\/iid3.851.","journal-title":"Immunity Inflamm Dis"},{"key":"350_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1101530","author":"S Cadena-Ullauri","year":"2023","unstructured":"Cadena-Ullauri S, Paz-Cruz E, Tamayo-Trujillo R, et al. Identification of KIT and BRAF mutations in thyroid tissue using next-generation sequencing in an Ecuadorian patient: a case report. Front Oncol. 2023. https:\/\/doi.org\/10.3389\/fonc.2022.1101530.","journal-title":"Front Oncol"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00350-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00350-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00350-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:11:55Z","timestamp":1781640715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43046-026-00350-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["350"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00350-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7920609\/v1","asserted-by":"object"}]},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted after obtaining approval through the Ethics Committee of the Faculty of Medicine, Tanjungpura University (NO. 7367\/UN22.9\/PG\/2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}